SHAREHOLDER ALERT: WeissLaw LLP Reminds CORE, ALTA, ARPO, and ONDS Shareholders About Its Ongoing Investigations

NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) --

If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:

Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY 10036
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com

Core-Mark Holding Company, Inc. (NASDAQ: CORE)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Core-Mark Holding Company, Inc. (NASDAQ: CORE) in connection with the company’s proposed acquisition by Performance Food Group Company (“PFG”). Pursuant to the merger agreement, Core-Mark’s shareholders will receive $23.875 in cash and 0.44 PFG shares for each Core-Mark share they own, representing implied per-share merger consideration of approximately $45.69 based upon PFG’s May 25, 2021 closing price of $49.59. The transaction is valued at approximately $2.5 billion.   If you own CORE shares and wish to discuss this investigation or your rights, please call us or visit our website: https://weisslawllp.com/core/

Altabancorp (NASDAQ: ALTA)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Altabancorp (NASDAQ: ALTA) in connection with the company’s proposed merger with Glacier Bancorp, Inc. (“Glacier”).   Pursuant to the merger agreement, ALTA shareholders will receive 0.7971 shares of Glacier stock for each ALTA share they own, representing implied per-share merger consideration of approximately $45.36 based upon Glacier’s May 25, 2021 closing price of $56.91. If you own ALTA shares and wish to discuss this investigation or your rights, please call us or visit our website:  https://www.weisslawllp.com/alta/

Aerpio Pharmaceuticals, Inc. (NASDAQ: ARPO)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Aerpio Pharmaceuticals, Inc. (NASDAQ: ARPO) in connection with the proposed merger of the company with privately-held Aadi Bioscience, Inc. Pursuant to the merger agreement, the two companies will combine their businesses in an all-stock transaction that will result in one combined entity that will trade publicly on the NASDAQ. If you own ARPO shares and wish to discuss this investigation or your rights, please call us or visit our website: https://weisslawllp.com/arpo/

Ondas Holdings Inc. (NASDAQ: ONDS)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Ondas Holdings Inc. (NASDAQ: ONDS) in connection with the company’s proposed acquisition of American Robotics, Inc. in a mixed cash-and-stock transaction. Pursuant to the merger agreement, ONDS will acquire American Robotics for (a) cash consideration of approximately $7,500,000, (b) 6,750,000 shares of ONDS common stock, (c) warrants exercisable for 1,875,000 shares of ONDS common stock, and (d) a potential cash payment released to ONDS stockholders from the company’s PPP Loan Escrow Amount. If you own ONDS shares and wish to discuss this investigation or your rights, please call us or visit our website: https://weisslawllp.com/news/onds/


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.